EDMONTON, Alta.--Bioinformatics software provider BioTools recently announced that it has entered into a strategic partnership with Tokyo-based Sawady Technology to promote, market, and sell BioTools's custom peptide synthesis services to customers in Japan and Asia under a nonexclusive license. The partnership is worth approximately $500,000 in annual peptide synthesis revenues to BioTools, the company stated.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.